Newsfeeds Archive - Spark Newswire

2 minute read

Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses

April 25, 9:48 AM

Canadian cannabis companyÂ Adastra Holdings Ltd.Â (CSE:XTRX)(FRA:D2EP) (OTCPK:XTXXF) itsÂ financial results reported Tuesday for the fourth quarter and the year ended…

CSE:XTRX

3 minute read

Cannabis Stock Gainers And Losers From August 24, 2023

By Benzinga Insights

August 24, 5:30 PM

GAINERS: EVIO (OTC:EVIO) shares closed up 9900.00% at $0.0001 Red White & Bloom Brands (OTC:RWBYF) shares closed up…

AAWH

2 minute read

Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2

By Nina Zdinjak

August 18, 11:07 AM

Candian marijuana operator Adastra Holdings Ltd. (OTC: XTXXF)(CSE:XTRX)(FRA:D2EP) reported Thursday financial results for the three months ended June 30, 2023, disclosing net revenue of CA$7.1 million, up by 132.68% year-over-year.

CSE:XTRX

2 minute read

Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What’s Behind The Figures?

By Jelena Martinovic

May 31, 1:33 PM

Cannabis producer Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTC: XTXXF) reported on Tuesday financial results for the three months ended March 31, 2023.

CSE:XTRX

2 minute read

Adastra FY22 Revenue Grows 136%, Here Is What You Need To Know

By Vuk Zdinjak

May 2, 9:10 AM

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) FY 2022 net revenue increased 136% to CA$13.3 million ($9.8 million), compared to CA$5.6 million in FY 2021. FY 2022 Financial Highlights Gross profit of CA$6.1 million, an increase of 214% compared CA$1.9 million in FY2021.

CSE:XTRX

2 minute read

Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit

By Vuk Zdinjak

March 16, 10:55 AM

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) has been served with a civil claim filed in the Supreme Court of British Columbia pursuant to the Class Proceedings Act, R.S.B.C. 1996, c. 50 alleging that the company's press release of February 22, 2023 misstated certain material facts which mislead the plaintiff in the claim.

CSE:XTRX

5 minute read

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More

By Lara Goldstein

March 13, 5:13 PM

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

ATAI

6 minute read

Psyched: 9 US Reform Bills, Ayahuasca ‘A Release’ For Prince Harry, At-Home Therapy & More

By Lara Goldstein

March 7, 11:29 AM

Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been held and various measures have been considered around the legalization of psychedelics. Let’s go over the latest proposed regulations.

AGNPF

2 minute read

Adastra Clarifies Health Canada Approval To Handle Cocaine

By Vuk Zdinjak

March 6, 9:18 AM

Adastra Labs Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) provided clarification regarding its receipt of Health Canada approval for the amendment to include cocaine under its controlled substances license.

CSE:XTRX

2 minute read

Canadian Weed Company’s Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment

By Jelena Martinovic

March 3, 12:15 PM

A Langley, British Columbia, cannabis company got the green light from Health Canada to produce and sell cocaine earlier this month, but the province's Premier says he was unaware of the mo

XTXXF